ICMR issues advisory for use of Feluda paper strip test
Friday, 23 October 2020 The paper-strip uses cutting-edge CRISPR gene-editing technology to identify and target the genetic material of SARS-CoV-2, the virus that causes Covid-19 in less than an hour. As claimed by the manufacturer, no further RT-PCR based confirmation is required for samples that are confirmed as positive or negative by the CRISPR SARS-CoV-2 test, the advisory issued on Thursday stated.
Routine testing patients for COVID-19 before major surgery could reduce the risk of respiratory complications and save lives, a new study revealed. Researchers working together around the world found that using a nasal swab test to confirm that asymptomatic patient was not infected with SARS-CoV-2 was associated with a lower rate of postoperative complications. The main benefit was seen before major surgery and areas with a higher rate of COVID-19. Swab testing gave an opportunity for surgeons to identify asymptomatic infected patients and postpone their operation, avoiding the severe risk of COVID-19 complications after surgery. Routine testing also helped to prevent cross-infection from patients with no symptoms to other elective surgical patients upon admission to hospital. The COVIDSurg toolkit will support individual hospitals, regions, and countries during a major global reorganisation of surgical services during the pandemic and beyond.
A new open source, a cloud-based tool called IDseq makes it possible to rapidly detect, identify, and track emerging pathogens such as SARS-CoV-2. This tool can identify pathogens before there is an available complete genome sequence; thus, it can be used for current infectious disease outbreaks and also for emerging ones. This will substantially aid in preventing future pandemics. The study was published in the journalGigaScience. The coronavirus pandemic demonstrates the importance of global infectious disease monitoring. Finding the cause of an infectious disease outbreak is challenging, especially if it stems from a previously unknown pathogen. IDseq, an open-source, cloud-based metagenomic analysis platform, identifies both novel and existing disease-causing pathogens from a given sample - be it a human, animal, or parasite - to provide an actionable report of what is happening on the ground in labs and clinics anywhere in the world. The new user-friendly IDseq software is open source and freely available to the global health community, reducing the barrier of entry to metagenomics.
Scientists have estimated that the age of an individual does not indicate how likely they are to be infected by SARS-CoV-2. However, the development of symptoms, the progression of the disease, and mortality are age-dependent. There have been a large number of deaths due to the ongoing COVID-19 pandemic, and it has been shown that elderly individuals disproportionately develop severe symptoms and show higher mortality. A team of scientists, including Associate Professor Ryosuke Omori from the Research Center for Zoonoses Control at Hokkaido University, have modelled available data from Japan, Spain and Italy to show that susceptibility to COVID-19 is independent of age, while the occurrence of symptomatic COVID-19, severity and mortality is likely dependent on age. Their results were published in the journal Scientific Reports on October 6, 2020.
Bengal’s legendary actor Soumitra Chatterjee passed away at the age of 85. Chatterjee died after over-a-month-long battle with multiple ailments. He was admitted to hospital on October 6 after he tested positive for Covid-19. He recovered from the infection, but his condition did not improve. Chatterjee acted in 14 Satyajit Ray films and over 300 others. He made his debut in Ray's 1959 film Apur Sansar. He was the first actor to play the role of Feluda, the detective created by Ray. The iconic actor is survived by his wife, son and daughter. Watch the full video for more.
Credit: HT Digital Content Duration: 02:02Published
As per the data released by Ministry of Health and Family Welfare, India on November 29 reported single-day spike of 41,810 new coronavirus cases in the last 24 hours. 496 deaths in the same period pushed the COVID-19 toll in the country to 1,36,696. India's confirmed cases of coronavirus stand at 93,92,920 which include 4,53,956 active infections. More than 88,02,267 people have recovered from the virus with 42,298 new discharges in last 24 hours. According to Indian Council of Medical Research (ICMR), a total of 12,83,449 samples were tested on November 28. Cumulative samples tested for COVID-19 till November 28 are 13,95,03,803.
Prime Minister Narendra Modi visited the Bharat Biotech facility in Telangana's Hyderabad on November 28. He arrived in the city after a tour of Zydus' facility in Gujarat's Ahmedabad earlier in the day. PM Modi is on a 3-city tour to take stock of Covid vaccine development in the country. He tweeted about his Bharat Biotech tour, hailing scientists for the progress in the trials so far. He added that the Bharat Biotech team is working with Indian Council of Medical Research for speedy progress. PM's next stop is the Serum Institute of India in Maharashtra's Pune. Watch the full video for more.
Credit: HT Digital Content Duration: 01:41Published
Brihanmumbai Municipal Corporation (BMC) will start pilot project of Artificial Intelligence-based voice detection test for COVID-19. Maharashtra authorities had approached Israel based health company to assess risk of COVID through voice by "bio markers". Nesco Center which has been converted into quarantine center was chosen for research. RT-PCR test could follow if this screening tool indicates high risk.
COVID-19 tests are being done on passengers arriving from Delhi, Goa, Rajasthan and Gujarat at Pune Railway Station. A doctor said, "Passengers with high temperature are undergoing Rapid Antigen Test; if positive, being shifted to hospital. We are keeping record." The Maharashtra government on November 23 imposed restrictions on travellers who wish to come to the state from heavily coronavirus-afflicted states like Rajasthan, Delhi, Gujarat and Goa. The restrictions are imposed on both rail or air travellers. The travellers have to undergone an RT-PCR test.
A mandatory RT-PCR test rule began in Mumbai from November 25 (Wednesday) amid rising cases of coronavirus pandemic. Travellers from Delhi, Rajasthan, Goa and Gujarat arrived at Mumbai's Dadar Railway Station to undergo mandatory RT-PCR test.